Zoar Limited, a pharmaceutical company, focuses on the development and manufacture of active pharmaceutical ingredients. It also provides contract development and manufacturing services to pharmaceutical and biotechnology companies worldwide. The company was founded in 2012 and is headquartered in Grand Cayman, the Cayman Islands.
前收盤價
US$3.38
−US$0.98 · -22.48%
盤中時間採用ET。市場資料可能有所延遲。
Zoar Limited, a pharmaceutical company, focuses on the development and manufacture of active pharmaceutical ingredients. It also provides contract development and manufacturing services to pharmaceutical and biotechnology companies worldwide. The company was founded in 2012 and is headquartered in Grand Cayman, the Cayman Islands.
日內區間
目前US$3.38
52週區間
目前US$3.38
盤中時間採用ET。市場資料可能有所延遲。
Zoar Limited, a pharmaceutical company, focuses on the development and manufacture of active pharmaceutical ingredients. It also provides contract development and manufacturing services to pharmaceutical and biotechnology companies worldwide. The company was founded in 2012 and is headquartered in Grand Cayman, the Cayman Islands.
日內區間
目前US$3.38
52週區間
目前US$3.38
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。